Search - tctmd.com

Displaying 761 - 780 of 1348

Sort: Relevancy | Date

Presentation TCT 2017

What Needs to Be Shown Before Renal Denervation Can Be Used in Clinical Practice?

Presenter: Michael Böhm, Thomas F. Luscher, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Sensing Renal Nerve Activity Before, During, and After Denervation: Autonomix

Presenter: Michael Böhm, Thomas F. Luscher, Robert S. Schwartz

October 30, 2017

Presentation TCT 2017

Diagnostic Mapping and Functional Assessment of the Renal Nerves: The Pythagoras Device

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Alcohol-Mediated Renal Denervation With a Higher-Dose: From the European Registry to Target BP 1

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Vessix RE-INFORCE Trial Update

Presenter: Michael Böhm, Thomas F. Luscher, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Catheter-Based Ultrasound Renal Denervation: RADIANCE Trial Update

Presenter: Michael Böhm, Thomas F. Luscher, Laura Mauri

October 30, 2017

Presentation TCT 2017

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Presenter: Martin B. Leon, Patrick T. O'Gara, Olaf Wendler

October 30, 2017

Presentation TCT 2017

Take-home Messages for Managing Aortic Valve Disease From the 2017 AHA/ACC Focused Update

Presenter: Martin B. Leon, Patrick T. O'Gara, Allan Schwartz

October 30, 2017

Presentation TCT 2017

KONAs WAVE IV Randomized Trial: Principal Results and Lessons Learned

Presenter: Michael Böhm, Thomas F. Luscher, Melvin D. Lobo

October 30, 2017

Presentation TCT 2017

First Results From the SPYRAL Hypertension Program (OFF-MED Study)

Presenter: Michael Böhm, Thomas F. Luscher

October 30, 2017

Presentation TCT 2017

Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives

Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud

October 30, 2017

Presentation TCT 2017

Mitraclip Patient Selection and Outcomes 2017: Who Is NOT Anatomically Eligible (Or in Whom Are the Results Suboptimal or Not Durable)?

Presenter: Ted Feldman, Scott Lim, Saibal Kar

October 30, 2017

Presentation TCT 2017

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

What is the Optimal Therapy for Hypertension?

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

Presentation TCT 2017

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou

October 30, 2017

Presentation TCT 2017

Case Presentation: Management of a Major SFA Dissection

Presenter: Michael Guiry, Julie Logan, Herbert D. Aronow

October 30, 2017

Presentation TCT 2017

SFA Dissections: Implications and Management

Presenter: Michael Guiry, Julie Logan, William A. Gray

October 30, 2017

Presentation TCT 2017

Debate: How should SFA Disease be Treated? In most cases DCB (± BMS)

Presenter: D. Christopher Metzger

October 30, 2017

Advertisement

What Needs to Be Shown Before Renal Denervation Can Be Used in Clinical Practice?

Sensing Renal Nerve Activity Before, During, and After Denervation: Autonomix

Diagnostic Mapping and Functional Assessment of the Renal Nerves: The Pythagoras Device

Alcohol-Mediated Renal Denervation With a Higher-Dose: From the European Registry to Target BP 1

Vessix RE-INFORCE Trial Update

Catheter-Based Ultrasound Renal Denervation: RADIANCE Trial Update

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Take-home Messages for Managing Aortic Valve Disease From the 2017 AHA/ACC Focused Update

KONAs WAVE IV Randomized Trial: Principal Results and Lessons Learned

First Results From the SPYRAL Hypertension Program (OFF-MED Study)

Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives

Mitraclip Patient Selection and Outcomes 2017: Who Is NOT Anatomically Eligible (Or in Whom Are the Results Suboptimal or Not Durable)?

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

What is the Optimal Therapy for Hypertension?

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

New U.S. Hypertension Guidelines and Treatment Targets

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Case Presentation: Management of a Major SFA Dissection

SFA Dissections: Implications and Management

Debate: How should SFA Disease be Treated? In most cases DCB (± BMS)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content